{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:d01d5beb-c5b9-4c3e-b620-4d022cf99676", "type": "composite", "version": "1", "versioncreated": "2026-10-20T01:00:11.418892Z", "firstcreated": "2026-10-20T01:00:11.418892Z", "pubstatus": "usable", "language": "en", "headline": "Baseline Genomic and Epigenetic Features Linked to MRD Status in Multiple Myeloma Quadruplet Therapy", "description_text": "A multiomic analysis of samples from newly diagnosed multiple myeloma patients treated with isatuximab, carfilzomib, lenalidomide and dexamethasone found that baseline genomic, transcriptomic and epigenetic features are associated with minimal residual disease status after induction therapy.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:cf983d96-7b3a-4520-999e-c03d770efb9f", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-20T01:00:16.135305Z", "firstcreated": "2026-10-20T01:00:11.418892Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "Baseline Genomic and Epigenetic Features Linked to MRD Status in Multiple Myeloma Quadruplet Therapy", "byline": "Jenna Mercer", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Science Official", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "A multiomic analysis of samples from newly diagnosed multiple myeloma patients treated with isatuximab, carfilzomib, lenalidomide and dexamethasone found that baseline genomic, transcriptomic and epigenetic features are associated with minimal residual disease status after induction therapy.", "altids": {"mosaic": "cf983d96-7b3a-4520-999e-c03d770efb9f", "story": "d01d5beb-c5b9-4c3e-b620-4d022cf99676", "slug": "baseline-genomic-and-epigenetic-features-linked-to-mrd-status-in-multiple-myeloma-quadruplet-therapy"}, "subject": [{"name": "Health", "rel": "direct", "literal": "health", "code": "medtop:07000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/07000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "A multiomic analysis of samples from newly diagnosed multiple myeloma patients treated with isatuximab, carfilzomib, lenalidomide and dexamethasone found that baseline genomic, transcriptomic and epigenetic features are associated with minimal residual disease status after induct", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:9e8d61a7-40e0-4e89-8b3d-7e56da81fbab", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy", "description_text": "Baseline Genomic and Epigenetic Features Linked to MRD Status in Multiple Myeloma Quadruplet Therapy", "copyrightholder": "en.wikipedia.org", "copyrightnotice": "Biopsy", "usageterms": "File-level licence not yet resolved from Commons; fetch the original for exact terms.", "altids": {"wireva": "9e8d61a7-40e0-4e89-8b3d-7e56da81fbab"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Wikimedia — licence per file", "licence_url": "https://commons.wikimedia.org/wiki/Commons:Reusing_content_outside_Wikimedia", "licence_raw": "Wikipedia page image", "licence_verified_at": "2026-10-20T01:00:16.167066Z", "attribution_required": true, "attribution_text": "Biopsy", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "en.wikipedia.org", "source_url": "https://en.wikipedia.org/wiki/Biopsy", "source_page_url": "https://en.wikipedia.org/wiki/Biopsy", "our_page_url": "https://scienceofficial.org/medicine/baseline-genomic-and-epigenetic-features-linked-to-mrd-status-in-multiple-myeloma-quadruplet-therapy/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/28d4ec653b6d4082849f78e4bfc4efaa0faec7ca51771b8a38cd8dee4e4651a8.jpg", "mimetype": "image/jpeg", "width": 1200, "height": 900}, "source": {"href": "https://en.wikipedia.org/wiki/Biopsy", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:d01d5beb-c5b9-4c3e-b620-4d022cf99676", "slug": "baseline-genomic-and-epigenetic-features-linked-to-mrd-status-in-multiple-myeloma-quadruplet-therapy-20261020", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Science Official", "canonical_required": true, "canonical_url": "https://scienceofficial.org/medicine/baseline-genomic-and-epigenetic-features-linked-to-mrd-status-in-multiple-myeloma-quadruplet-therapy/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "single_source", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.", "independence_check": {"status": "failed", "score": 0.905, "checked_at": "2026-10-20T01:00:16.160707Z"}, "sources": [{"url": "https://www.nature.com/articles/s41591-026-04692-0", "title": "Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy", "publisher": "nature.com", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-10-20T01:00:16.143403Z", "published_at": "2026-10-18T23:00:00Z"}]}, "wireva:publication": {"name": "Science Official", "domain": "scienceofficial.org", "country": "US", "url": "https://scienceofficial.org/medicine/baseline-genomic-and-epigenetic-features-linked-to-mrd-status-in-multiple-myeloma-quadruplet-therapy/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/cf983d96-7b3a-4520-999e-c03d770efb9f", "html": "https://wireva.mib.news/item/cf983d96-7b3a-4520-999e-c03d770efb9f/baseline-genomic-and-epigenetic-features-linked-to-mrd-status-in-multiple-myeloma-quadruplet-therapy/", "story": "https://wireva.mib.news/story/baseline-genomic-and-epigenetic-features-linked-to-mrd-status-in-multiple-myeloma-quadruplet-therapy-20261020/"}, "wireva:metrics": {"word_count": 301, "char_count": 2205, "reading_time_seconds": 158}}}}, "extra": {"wireva:languages": ["en"], "wireva:status": "developing", "wireva:item_count": 1}}